Universitario de la Princesa Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2015
NCT02361060
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Enrique Alday Muñoz | Instituto de Investigación Sanitaria Hospital Universitario de la Princesa

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7